导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 39.57% | 86/1050 |
| 近一周 | -1.21% | 162/1104 |
| 近一月 | -9.42% | 1011/1102 |
| 近一季 | -9.52% | 638/1092 |
| 近半年 | 40.31% | 33/1070 |
| 近一年 | 48.57% | 81/1018 |
| 近两年 | 165.34% | 82/926 |
| 近三年 | 103.49% | 89/834 |
| 成立以来 | 375.43% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.86% 806/1070 |
107.87% 22/1101 |
- - |
- - |
| 2025 | 50.63% 189/1065 |
8.71% 192/1014 |
-2.78% 880/1038 |
45.19% 124/1050 |
-1.84% 547/1065 |
| 2024 | 0.29% 572/1011 |
-2.88% 470/960 |
-6.64% 724/983 |
6.89% 824/991 |
3.49% 178/1011 |
| 2023 | -4.01% 180/952 |
19.81% 31/880 |
-0.10% 196/895 |
-17.46% 825/915 |
-2.84% 310/952 |
| 2022 | -29.51% 616/867 |
-21.52% 605/773 |
16.15% 91/806 |
-21.58% 773/845 |
-1.40% 506/867 |
| 2021 | 43.34% 29/740 |
-12.49% 534/580 |
42.71% 5/659 |
9.63% 68/704 |
4.69% 240/740 |
| 2020 | 94.64% 48/554 |
-2.33% 222/419 |
33.69% 83/466 |
9.50% 262/517 |
36.14% 19/554 |
| 2019 | 62.19% 70/410 |
36.84% 109/1146 |
-8.51% 936/1228 |
6.90% 165/390 |
21.20% 12/410 |
| 2018 | - - |
- - |
- - |
-3.78% 404/1000 |
8.06% 2/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 金鹰信息产业股票C VS. 东吴新产业精选股票A(580008) |